Compounds > erlotinib hydrochloride
Page last updated: 2024-09-05

erlotinib hydrochloride and Carcinoma, Lewis Lung

erlotinib hydrochloride has been researched along with Carcinoma, Lewis Lung in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (50.00)24.3611
2020's2 (50.00)2.80

Authors

AuthorsStudies
Agca, S; Arabaci, DH; Bilgic, SN; Domaniku, A; Kir, S; Weber, BZC1
Chen, PC; Guo, CH; Hsia, S; Lee, SY; Li, WC; Peng, CL1
He, Y; Su, Z; Xu, H; Xue, L; Zhang, C1
Kawahara, K; Maeda, T; Watanabe, S; Yamada, D1

Other Studies

4 other study(ies) available for erlotinib hydrochloride and Carcinoma, Lewis Lung

ArticleYear
Inhibition of epidermal growth factor receptor suppresses parathyroid hormone-related protein expression in tumours and ameliorates cancer-associated cachexia.
    Journal of cachexia, sarcopenia and muscle, 2022, Volume: 13, Issue:3

    Topics: Animals; Cachexia; Carcinoma, Lewis Lung; Carcinoma, Non-Small-Cell Lung; ErbB Receptors; Erlotinib Hydrochloride; Genes, erbB-1; Head and Neck Neoplasms; Humans; Ligands; Lung Neoplasms; Mice; Parathyroid Hormone-Related Protein; RNA, Messenger; Squamous Cell Carcinoma of Head and Neck

2022
Targeting EGFR in Combination with Nutritional Supplements on Antitumor Efficacy in a Lung Cancer Mouse Model.
    Marine drugs, 2022, Nov-29, Volume: 20, Issue:12

    Topics: Animals; Antineoplastic Combined Chemotherapy Protocols; Carcinoma, Lewis Lung; Dietary Supplements; ErbB Receptors; Erlotinib Hydrochloride; Fish Oils; Gefitinib; Glycogen Synthase Kinase 3 beta; Mice; Protein Kinase Inhibitors; Selenium

2022
Co-delivery of erlotinib and doxorubicin by pH-sensitive charge conversion nanocarrier for synergistic therapy.
    Journal of controlled release : official journal of the Controlled Release Society, 2016, 05-10, Volume: 229

    Topics: A549 Cells; Animals; Antineoplastic Agents; Apoptosis; Benzoates; Carcinoma, Lewis Lung; Cell Survival; Doxorubicin; Drug Carriers; Drug Liberation; Drug Synergism; Drug Therapy, Combination; Erlotinib Hydrochloride; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred C57BL; Nanoparticles; Phosphatidylcholines; Protein Kinase Inhibitors; Rats, Sprague-Dawley

2016
Plexin A1 signaling confers malignant phenotypes in lung cancer cells.
    Biochemical and biophysical research communications, 2016, Nov-04, Volume: 480, Issue:1

    Topics: Animals; Apoptosis; Carcinoma, Lewis Lung; Cell Line, Tumor; Cell Proliferation; Erlotinib Hydrochloride; Gefitinib; Gene Expression Regulation, Neoplastic; Gene Knockdown Techniques; Glucose; Mice; Nerve Tissue Proteins; Protein Kinase Inhibitors; Quinazolines; Receptors, Cell Surface; RNA, Small Interfering; Semaphorin-3A; Signal Transduction

2016